{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:38:32Z","timestamp":1786365512507,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10549-025-07608-7","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:08:16Z","timestamp":1736874496000},"page":"699-707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sentinel lymph node biopsy in breast cancer: the role of ICG fluorescence after neoadjuvant chemotherapy"],"prefix":"10.1007","volume":"210","author":[{"given":"Pawe\u0142","family":"Bogacz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3312-9586","authenticated-orcid":false,"given":"Zuzanna","family":"Pelc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rados\u0142aw","family":"Mlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"S\u0119d\u0142ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kobia\u0142ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Mielniczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Le\u015bniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Chawrylak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Polkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Rawicz-Pruszy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Kurylcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"7608_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA: A Cancer J Clin"},{"key":"7608_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071565","author":"M Banys-Paluchowski","year":"2021","unstructured":"Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S et al (2021) Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the EUBREAST-03 AXSANA Study. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13071565","journal-title":"Cancers (Basel)"},{"key":"7608_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0960-7404(93)90064-6","volume":"2","author":"DN Krag","year":"1993","unstructured":"Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335\u2013339. https:\/\/doi.org\/10.1016\/0960-7404(93)90064-6","journal-title":"Surg Oncol"},{"key":"7608_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","volume":"220","author":"AE Giuliano","year":"1994","unstructured":"Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391\u2013398. https:\/\/doi.org\/10.1097\/00000658-199409000-00015","journal-title":"Ann Surg"},{"key":"7608_CR5","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.21873\/anticanres.12642","volume":"38","author":"W Malter","year":"2018","unstructured":"Malter W, Hellmich M, Badian M, Kirn V, Mallmann P, Kramer S (2018) Factors predictive of sentinel lymph node involvement in primary breast cancer. Anticancer Res 38:3657\u20133662. https:\/\/doi.org\/10.21873\/anticanres.12642","journal-title":"Anticancer Res"},{"key":"7608_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","volume":"20","author":"WJ Gradishar","year":"2022","unstructured":"Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH et al (2022) Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 20:691\u2013722. https:\/\/doi.org\/10.6004\/jnccn.2022.0030","journal-title":"J Natl Compr Canc Netw"},{"key":"7608_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.016","author":"S Loibl","year":"2023","unstructured":"Loibl S, Andre F, Bachelot T, Barrios CH, Bergh J, Burstein HJ et al (2023) Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up(dagger). Ann Oncol. https:\/\/doi.org\/10.1016\/j.annonc.2023.11.016","journal-title":"Ann Oncol"},{"key":"7608_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","volume":"3","author":"M Pilewskie","year":"2017","unstructured":"Pilewskie M, Morrow M (2017) Axillary nodal management following neoadjuvant chemotherapy: a review. JAMA Oncol 3:549\u2013555. https:\/\/doi.org\/10.1001\/jamaoncol.2016.4163","journal-title":"JAMA Oncol"},{"key":"7608_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10549-020-05843-8","volume":"184","author":"JM Dixon","year":"2020","unstructured":"Dixon JM, Grewar J, Twelves D, Graham A, Martinez-Perez C, Turnbull A (2020) Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer. Breast Cancer Res Treat 184:335\u2013343. https:\/\/doi.org\/10.1007\/s10549-020-05843-8","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"7608_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/archsurg.142.5.456","volume":"142","author":"AB Chagpar","year":"2007","unstructured":"Chagpar AB, Scoggins CR, Martin RC, Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, McMasters KM (2007) Are 3 sentinel nodes sufficient? Archiv Surg 142(5):456\u2013460","journal-title":"Archiv Surg"},{"key":"7608_CR11","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/jco.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ et al (2016) Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol 34:1072\u20131078. https:\/\/doi.org\/10.1200\/jco.2015.64.0094","journal-title":"J Clin Oncol"},{"key":"7608_CR12","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","volume":"7","author":"AV Barrio","year":"2021","unstructured":"Barrio AV, Montagna G, Mamtani A, Sevilimedu V, Edelweiss M, Capko D et al (2021) Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy\u2014a rare event. JAMA Oncol 7:1851\u20131855. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4394","journal-title":"JAMA Oncol"},{"key":"7608_CR13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-16472-6","author":"N Cabioglu","year":"2024","unstructured":"Cabioglu N, Karanlik H, Igci A, Muslumanoglu M, Gulcelik MA, Uras C et al (2024) Breast cancer recurrence in initially clinically node-positive patients undergoing sentinel lymph node biopsy after neoadjuvant chemotherapy in the NEOSENTITURK-trials MF18-02\/18-03. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-024-16472-6","journal-title":"Ann Surg Oncol"},{"key":"7608_CR14","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1245\/s10434-010-0945-z","volume":"17","author":"ME Straver","year":"2010","unstructured":"Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J et al (2010) Sentinel node identification rate and nodal involvement in the EORTC 10981\u201322023 AMAROS trial. Ann Surg Oncol 17:1854\u20131861. https:\/\/doi.org\/10.1245\/s10434-010-0945-z","journal-title":"Ann Surg Oncol"},{"key":"7608_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10434-001-0013-9","volume":"8","author":"HS Cody 3rd","year":"2001","unstructured":"Cody HS 3rd, Fey J, Akhurst T, Fazzari M, Mazumdar M, Yeung H et al (2001) Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 8:13\u201319. https:\/\/doi.org\/10.1007\/s10434-001-0013-9","journal-title":"Ann Surg Oncol"},{"key":"7608_CR16","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.Sabcs15-p3-01-05","author":"J Unkart","year":"2016","unstructured":"Unkart J, Wallace A (2016) Abstract P3\u201301\u201305: the use of Tc-99 tilmanocept in sentinel lymph node biopsy after neoadjuvant chemotherapy in clinically node-negative patients with breast cancer. Cancer Res. https:\/\/doi.org\/10.1158\/1538-7445.Sabcs15-p3-01-05","journal-title":"Cancer Res"},{"key":"7608_CR17","doi-asserted-by":"crossref","unstructured":"Ferrucci, M.,Franceschini, G.,Douek, M. New techniques for sentinel node biopsy in breast cancer. Translat Cancer Res 2018, S405-S417.","DOI":"10.21037\/tcr.2018.02.07"},{"key":"7608_CR18","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.3390\/jcm10143149","volume":"10","author":"A Kurylcio","year":"2021","unstructured":"Kurylcio A, Pelc Z, Sk\u00f3rzewska M, Rawicz-Pruszy\u0144ski K, Mlak R, G\u0119ca K et al (2021) Superparamagnetic iron oxide for identifying sentinel lymph node in breast cancer after neoadjuvant chemotherapy: feasibility study. J Clin Med 10:3149","journal-title":"J Clin Med"},{"key":"7608_CR19","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1245\/s10434-019-07400-0","volume":"26","author":"SY Jung","year":"2019","unstructured":"Jung SY, Han JH, Park SJ, Lee EG, Kwak J, Kim SH et al (2019) The sentinel lymph node biopsy using indocyanine green fluorescence plus radioisotope method compared with the radioisotope-only method for breast cancer patients after neoadjuvant chemotherapy: a prospective, randomized, open-label, single-center phase 2 trial. Ann Surg Oncol 26:2409\u20132416. https:\/\/doi.org\/10.1245\/s10434-019-07400-0","journal-title":"Ann Surg Oncol"},{"key":"7608_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.amsu.2020.09.030","volume":"59","author":"P Chirappapha","year":"2020","unstructured":"Chirappapha P, Chatmongkonwat T, Lertsithichai P, Pipatsakulroj W, Sritara C, Sukarayothin T (2020) Sentinel lymph node biopsy after neoadjuvant treatment of breast cancer using blue dye, radioisotope, and indocyanine green: Prospective cohort study. Ann Med Surg (Lond) 59:156\u2013160. https:\/\/doi.org\/10.1016\/j.amsu.2020.09.030","journal-title":"Ann Med Surg (Lond)"},{"key":"7608_CR21","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/bjs\/znac217","volume":"109","author":"ML Gasparri","year":"2022","unstructured":"Gasparri ML, de Boniface J, Poortmans P, Gentilini OD, Kaidar-Person O, Banys-Paluchowski M et al (2022) Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey. Br J Surg 109:857\u2013863. https:\/\/doi.org\/10.1093\/bjs\/znac217","journal-title":"Br J Surg"},{"key":"7608_CR22","first-page":"207","volume":"16","author":"EJ Jassem","year":"2020","unstructured":"Jassem EJ, Krzakowski M, Jassem AJ, Krzakowski M, Bobek-Billewicz B, Duchnowska R et al (2020) Breast cancer. Oncol Clin Pract 16:207\u2013260","journal-title":"Oncol Clin Pract"},{"key":"7608_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1470-2045(21)00589-1","volume":"23","author":"C Yau","year":"2022","unstructured":"Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D et al (2022) Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Lancet Oncol 23:149\u2013160. https:\/\/doi.org\/10.1016\/S1470-2045(21)00589-1","journal-title":"Lancet Oncol"},{"key":"7608_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3332\/ecancer.2016.674","volume":"10","author":"MC Peek","year":"2016","unstructured":"Peek MC, Kovacs T, Baker R, Hamed H, Kothari A, Douek M (2016) Is blue dye still required during sentinel lymph node biopsy for breast cancer? Ecancermedicalscience 10:674. https:\/\/doi.org\/10.3332\/ecancer.2016.674","journal-title":"Ecancermedicalscience"},{"key":"7608_CR25","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.1200\/jco.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein HJ et al (2005) American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703\u20137720. https:\/\/doi.org\/10.1200\/jco.2005.08.001","journal-title":"J Clin Oncol"},{"key":"7608_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/s1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 14:609\u2013618. https:\/\/doi.org\/10.1016\/s1470-2045(13)70166-9","journal-title":"Lancet Oncol"},{"key":"7608_CR27","first-page":"893","volume":"9","author":"FE Sharkey","year":"1996","unstructured":"Sharkey FE, Addington SL, Fowler LJ, Page CP, Cruz AB (1996) Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol 9:893\u2013900","journal-title":"Mod Pathol"},{"key":"7608_CR28","doi-asserted-by":"publisher","first-page":"1507881","DOI":"10.1155\/2022\/1507881","volume":"2022","author":"S Aragon-Sanchez","year":"2022","unstructured":"Aragon-Sanchez S, Oliver-Perez MR, Madariaga A, Tabuenca MJ, Martinez M, Galindo A et al (2022) Accuracy and limitations of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive nodes. Breast J 2022:1507881. https:\/\/doi.org\/10.1155\/2022\/1507881","journal-title":"Breast J"},{"key":"7608_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12282-011-0286-1","volume":"19","author":"T Kitai","year":"2012","unstructured":"Kitai T, Kawashima M (2012) Transcutaneous detection and direct approach to the sentinel node using axillary compression technique in ICG fluorescence-navigated sentinel node biopsy for breast cancer. Breast Cancer 19:343\u2013348. https:\/\/doi.org\/10.1007\/s12282-011-0286-1","journal-title":"Breast Cancer"},{"key":"7608_CR30","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1245\/s10434-013-2890-0","volume":"20","author":"T Sugie","year":"2013","unstructured":"Sugie T, Sawada T, Tagaya N, Kinoshita T, Yamagami K, Suwa H et al (2013) Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol 20:2213\u20132218. https:\/\/doi.org\/10.1245\/s10434-013-2890-0","journal-title":"Ann Surg Oncol"},{"key":"7608_CR31","doi-asserted-by":"publisher","first-page":"6520","DOI":"10.1245\/s10434-023-13824-6","volume":"30","author":"CL Nguyen","year":"2023","unstructured":"Nguyen CL, Zhou M, Easwaralingam N, Seah JL, Azimi F, Mak C et al (2023) Novel dual tracer indocyanine green and radioisotope versus gold standard sentinel lymph node biopsy in breast cancer: the GREENORBLUE trial. Ann Surg Oncol 30:6520\u20136527. https:\/\/doi.org\/10.1245\/s10434-023-13824-6","journal-title":"Ann Surg Oncol"},{"key":"7608_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245755","author":"I Akrida","year":"2023","unstructured":"Akrida I, Michalopoulos NV, Lagadinou M, Papadoliopoulou M, Maroulis I, Mulita F (2023) An updated review on the emerging role of indocyanine green (ICG) as a sentinel lymph node tracer in breast cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15245755","journal-title":"Cancers (Basel)"},{"key":"7608_CR33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.breast.2015.02.034","volume":"24","author":"S Tsuyuki","year":"2015","unstructured":"Tsuyuki S, Yamaguchi A, Kawata Y, Kawaguchi K (2015) Assessing the effects of neoadjuvant chemotherapy on lymphatic pathways to sentinel lymph nodes in cases of breast cancer: usefulness of the indocyanine green-fluorescence method. Breast 24:298\u2013301. https:\/\/doi.org\/10.1016\/j.breast.2015.02.034","journal-title":"Breast"},{"key":"7608_CR34","doi-asserted-by":"publisher","first-page":"e0197857","DOI":"10.1371\/journal.pone.0197857","volume":"13","author":"I Veys","year":"2018","unstructured":"Veys I, Pop CF, Barbieux R, Moreau M, Noterman D, De Neubourg F et al (2018) ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy. PLoS ONE 13:e0197857. https:\/\/doi.org\/10.1371\/journal.pone.0197857","journal-title":"PLoS ONE"},{"key":"7608_CR35","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00432-020-03461-x","volume":"147","author":"P Staubach","year":"2021","unstructured":"Staubach P, Scharl A, Ignatov A, Ortmann O, Inwald EC, Hildebrandt T et al (2021) Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM((R)) fluorescence camera: a comparison between primary sentinel lymph node biopsy versus sentinel lymph node biopsy after neoadjuvant chemotherapy. J Cancer Res Clin Oncol 147:1813\u20131823. https:\/\/doi.org\/10.1007\/s00432-020-03461-x","journal-title":"J Cancer Res Clin Oncol"},{"key":"7608_CR36","doi-asserted-by":"publisher","first-page":"e32545","DOI":"10.1097\/MD.0000000000032545","volume":"101","author":"I Tasdoven","year":"2022","unstructured":"Tasdoven I, Balbaloglu H, Erdemir RU, Bahadir B, Guldeniz Karadeniz C (2022) Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy. Medicine (Baltimore) 101:e32545. https:\/\/doi.org\/10.1097\/MD.0000000000032545","journal-title":"Medicine (Baltimore)"},{"key":"7608_CR37","doi-asserted-by":"publisher","first-page":"e0309336","DOI":"10.1371\/journal.pone.0309336","volume":"19","author":"M Pinelli","year":"2024","unstructured":"Pinelli M, Gerardi C, Lettieri E, Maioru M, Marone L, Bertoldi L et al (2024) Comparison of Indocyanine Green with conventional tracers for sentinel lymph node biopsy in breast cancer: a multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact. PLoS ONE 19:e0309336. https:\/\/doi.org\/10.1371\/journal.pone.0309336","journal-title":"PLoS ONE"},{"key":"7608_CR38","doi-asserted-by":"publisher","first-page":"e0263227","DOI":"10.1371\/journal.pone.0263227","volume":"17","author":"F Schettini","year":"2022","unstructured":"Schettini F, Ferrario L, Foglia E, Garagiola E, Parodi L, Cavagnaro P et al (2022) The implementation of a standardized optimal procedure for peripheral venous catheters\u2019 management: results from a multi-dimensional assessment. PLoS ONE 17:e0263227. https:\/\/doi.org\/10.1371\/journal.pone.0263227","journal-title":"PLoS ONE"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07608-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07608-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07608-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:47:01Z","timestamp":1743382021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07608-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7608"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07608-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Medical University of Lublin (Ethic Code: KE-0254\/331\/2018) on the 20th of December 2018.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}